Gactiv approved in Japan for type 2 diabetes in combination with alpha-glucosidase inhibitors May 24, 2011
European Commission approves Eliquis for prevention of VTE after hip or knee replacement May 23, 2011
Boehringer Ingelheim and Lilly receive FDA approval for Tradjenta tablets in type 2 diabetes May 3, 2011
RSS